Vir Biotechnology VIR
NASDAQ VIR
$13.13 -0.02 (-0.15%)
At close: Nov 11, 2026 · 4:00 PM EST

Vir Biotechnology (VIR) Asset Writedowns and Impairment (2023 - 2024)

Updated

Analysis

Vir Biotechnology (VIR) Asset Writedowns and Impairment (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Vir Biotechnology 2.23 Bn 313.19 Mn 188,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 11.04 Mn
Dec 31, 2023 2.76 Mn
API Access

Vir Biotechnology Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=VIR&period=max&api_key=YOUR_API_KEY